Individualizing hormone therapy to minimize risk: accurate assessment of risks and benefits.

@article{Shoupe2011IndividualizingHT,
  title={Individualizing hormone therapy to minimize risk: accurate assessment of risks and benefits.},
  author={Donna Shoupe},
  journal={Women's health},
  year={2011},
  volume={7 4},
  pages={475-85}
}
Contrary to the exaggerated risks associated with HRT that developed after the initial press reports held by the Women's Health Initiative (WHI) writing group, the recent approach to hormone therapy is more balanced and evidence based. A review of over 40 years of scientific studies demonstrates that estrogen is a medication that can decrease mortality, cardiovascular disease, osteoporosis fracture, urogenital atrophy and dementia. When timing of administration, dose of therapy and route of… CONTINUE READING
6 Citations
61 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 61 references

principal results from the Women’s Health Initiative randomized controlled trial

  • JE Rossouw, GL Anderson, Prentice RL et al. Risks, benefits of estrogen plus progestin in healthy postmenopaus women
  • JAMA 288, 321–333
  • 2002
Highly Influential
7 Excerpts

For the WHI investigators. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women

  • T Rowan, RT Chlebowski, GL Anderson
  • JAMA 304(15),
  • 2010
1 Excerpt

Similar Papers

Loading similar papers…